Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
metabolics
Biotech
Septerna launches with $100M and GPCR pioneer co-founder
Septerna snagged $100 million and GPCR expert Robert Lefkowitz, to help steer the biotech toward the clinic in 2023.
Kyle LaHucik
Jan 27, 2022 7:00am
FDA hits Viking clinical hold over mix-up in phase of trial
Jan 24, 2022 8:35am
Lilly extends JPM collab theme in $1B Evotec pact, Abbisko deal
Jan 18, 2022 11:30am
Applied pumps brakes on FDA application after request for data
Jan 4, 2022 3:30pm
Eli Lilly pens $1.5B biobucks pact with China's Regor
Dec 10, 2021 7:40am
Potential new target for arthritis treatment pinpointed
Nov 24, 2021 10:00am
